Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Pete Stavropoulos is an analyst at Cantor Fitzgerald. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025
Buy Now | Get Alert | |||||||||
---|---|---|---|---|---|---|---|---|---|---|
03/12/2025 | VYGR | Buy Now | Voyager Therapeutics | $3.88 | — | Pete Stavropoulos46% | — | Reiterates | Overweight → Overweight | Get Alert |
03/07/2025 | ARCT | Buy Now | Arcturus Therapeutics | $13.73 | — | Pete Stavropoulos46% | — | Reiterates | Overweight → Overweight | Get Alert |
03/04/2025 | PLRX | Buy Now | Pliant Therapeutics | $1.72 | — | Pete Stavropoulos46% | — | Reinstates | → Neutral | Get Alert |
01/10/2025 | VYGR | Buy Now | Voyager Therapeutics | $3.88 | 47.49% | Pete Stavropoulos46% | → $5.73 | Initiates | → Overweight | Get Alert |
12/16/2024 | ARCT | Buy Now | Arcturus Therapeutics | $13.73 | — | Pete Stavropoulos46% | — | Reiterates | Overweight → Overweight | Get Alert |
12/09/2024 | KALV | Buy Now | KalVista Pharma | $12.47 | — | Pete Stavropoulos46% | — | Reiterates | Overweight → Overweight | Get Alert |
11/26/2024 | ALEC | Buy Now | Alector | $1.32 | — | Pete Stavropoulos46% | — | Reiterates | → Overweight | Get Alert |
11/15/2024 | ANNX | Buy Now | Annexon | $2.62 | — | Pete Stavropoulos46% | — | Reiterates | → Overweight | Get Alert |
10/18/2024 | VSTM | Buy Now | Verastem | $6.50 | — | Pete Stavropoulos46% | — | Reiterates | → Overweight | Get Alert |
10/03/2024 | VERA | Buy Now | Vera Therapeutics | $27.41 | 290.37% | Pete Stavropoulos46% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
10/01/2024 | VERA | Buy Now | Vera Therapeutics | $27.41 | 290.37% | Pete Stavropoulos46% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
09/23/2024 | VERA | Buy Now | Vera Therapeutics | $27.41 | 290.37% | Pete Stavropoulos46% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
09/16/2024 | VERA | Buy Now | Vera Therapeutics | $27.41 | 290.37% | Pete Stavropoulos46% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
09/09/2024 | VERA | Buy Now | Vera Therapeutics | $27.41 | 290.37% | Pete Stavropoulos46% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
09/06/2024 | VERA | Buy Now | Vera Therapeutics | $27.41 | 290.37% | Pete Stavropoulos46% | $107 → $107 | Reiterates | Overweight → Overweight | Get Alert |
08/08/2024 | PLRX | Buy Now | Pliant Therapeutics | $1.72 | — | Pete Stavropoulos46% | — | Reiterates | → Overweight | Get Alert |
08/06/2024 | ARCT | Buy Now | Arcturus Therapeutics | $13.73 | — | Pete Stavropoulos46% | — | Reiterates | → Overweight | Get Alert |
07/29/2024 | ALEC | Buy Now | Alector | $1.32 | — | Pete Stavropoulos46% | — | Reiterates | → Overweight | Get Alert |
06/27/2024 | DNTH | Buy Now | Dianthus Therapeutics | $20.74 | — | Pete Stavropoulos46% | — | Initiates | → Overweight | Get Alert |
06/20/2024 | ALEC | Buy Now | Alector | $1.32 | — | Pete Stavropoulos46% | — | Reiterates | → Overweight | Get Alert |
06/18/2024 | JSPR | Buy Now | Jasper Therapeutics | $5.22 | — | Pete Stavropoulos46% | — | Reiterates | → Overweight | Get Alert |
06/05/2024 | ANNX | Buy Now | Annexon | $2.62 | — | Pete Stavropoulos46% | — | Reiterates | → Overweight | Get Alert |
05/09/2024 | ALEC | Buy Now | Alector | $1.32 | — | Pete Stavropoulos46% | — | Reiterates | → Overweight | Get Alert |
04/24/2024 | ANNX | Buy Now | Annexon | $2.62 | — | Pete Stavropoulos46% | — | Reiterates | → Overweight | Get Alert |
04/03/2024 | ANNX | Buy Now | Annexon | $2.62 | — | Pete Stavropoulos46% | — | Reiterates | → Overweight | Get Alert |
01/08/2024 | VERA | Buy Now | Vera Therapeutics | $27.41 | — | Pete Stavropoulos46% | — | Initiates | → Overweight | Get Alert |
10/12/2023 | JSPR | Buy Now | Jasper Therapeutics | $5.22 | 14.94% | Pete Stavropoulos46% | → $60 | Reiterates | Overweight → Overweight | Get Alert |
09/22/2023 | ALEC | Buy Now | Alector | $1.32 | 884.85% | Pete Stavropoulos46% | → $13 | Initiates | → Overweight | Get Alert |
09/19/2023 | RZLT | Buy Now | Rezolute | $3.37 | 48.37% | Pete Stavropoulos46% | → $5 | Reiterates | Overweight → Overweight | Get Alert |
08/22/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.72 | 3562.79% | Pete Stavropoulos46% | → $63 | Reiterates | Overweight → Overweight | Get Alert |
08/22/2023 | ARCT | Buy Now | Arcturus Therapeutics | $13.73 | 293.3% | Pete Stavropoulos46% | → $54 | Reiterates | Overweight → Overweight | Get Alert |
08/22/2023 | ANNX | Buy Now | Annexon | $2.62 | 396.18% | Pete Stavropoulos46% | → $13 | Reiterates | Overweight → Overweight | Get Alert |
08/08/2023 | ANNX | Buy Now | Annexon | $2.62 | 396.18% | Pete Stavropoulos46% | $18 → $13 | Maintains | Overweight | Get Alert |
08/01/2023 | ANNX | Buy Now | Annexon | $2.62 | 587.02% | Pete Stavropoulos46% | → $18 | Reiterates | Overweight → Overweight | Get Alert |
07/17/2023 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.21 | 974.38% | Pete Stavropoulos46% | → $13 | Reiterates | Overweight → Overweight | Get Alert |
07/14/2023 | ARCT | Buy Now | Arcturus Therapeutics | $13.73 | 293.3% | Pete Stavropoulos46% | → $54 | Reiterates | Overweight → Overweight | Get Alert |
06/28/2023 | RZLT | Buy Now | Rezolute | $3.37 | 48.37% | Pete Stavropoulos46% | $7 → $5 | Maintains | Overweight | Get Alert |
06/27/2023 | ORTX | Buy Now | Orchard Therapeutics | — | — | Pete Stavropoulos46% | → $15 | Reiterates | Overweight → Overweight | Get Alert |
05/18/2023 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.21 | 974.38% | Pete Stavropoulos46% | → $13 | Initiates | → Overweight | Get Alert |
05/01/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.72 | 3562.79% | Pete Stavropoulos46% | $52 → $63 | Maintains | Overweight | Get Alert |
03/28/2023 | ORTX | Buy Now | Orchard Therapeutics | — | — | Pete Stavropoulos46% | $3 → $15 | Maintains | Overweight | Get Alert |
03/20/2023 | IMNM | Buy Now | Immunome | $8.50 | -5.88% | Pete Stavropoulos46% | → $8 | Reiterates | → Overweight | Get Alert |
03/14/2023 | ANNX | Buy Now | Annexon | $2.62 | 587.02% | Pete Stavropoulos46% | $22 → $18 | Maintains | Overweight | Get Alert |
03/09/2023 | JSPR | Buy Now | Jasper Therapeutics | $5.22 | 14.94% | Pete Stavropoulos46% | → $60 | Reiterates | → Overweight | Get Alert |
02/07/2023 | JSPR | Buy Now | Jasper Therapeutics | $5.22 | 14.94% | Pete Stavropoulos46% | $100 → $60 | Reiterates | → Overweight | Get Alert |
01/23/2023 | PLRX | Buy Now | Pliant Therapeutics | $1.72 | 2923.26% | Pete Stavropoulos46% | $40 → $52 | Maintains | Overweight | Get Alert |
11/02/2022 | ARCT | Buy Now | Arcturus Therapeutics | $13.73 | 220.47% | Pete Stavropoulos46% | $39 → $44 | Maintains | Overweight | Get Alert |
08/16/2022 | ANNX | Buy Now | Annexon | $2.62 | 739.69% | Pete Stavropoulos46% | $27 → $22 | Maintains | Overweight | Get Alert |
06/15/2022 | RZLT | Buy Now | Rezolute | $3.37 | 167.06% | Pete Stavropoulos46% | → $9 | Initiates | → Overweight | Get Alert |